Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Viral genome search in myocardium of patients with fulminant myocarditis.

Veronese G, Ammirati E, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun OÖ, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foà A, Leone O, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Murohara T, Arita Y, Sionis A, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Greenberg B, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG.

Eur J Heart Fail. 2020 Jan 11. doi: 10.1002/ejhf.1738. [Epub ahead of print] No abstract available.

PMID:
31926056
2.

Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset.

Ditaranto R, Boriani G, Biffi M, Lorenzini M, Graziosi M, Ziacchi M, Pasquale F, Vitale G, Berardini A, Rinaldi R, Lattanzi G, Potena L, Martin Suarez S, Bacchi Reggiani ML, Rapezzi C, Biagini E.

Orphanet J Rare Dis. 2019 Nov 19;14(1):263. doi: 10.1186/s13023-019-1245-8.

3.

Soluble HLA-G pre-transplant levels to identify the risk for development of infection in heart transplant recipients.

Bortolotti D, Gentili V, Rotola A, Potena L, Rizzo R.

Hum Immunol. 2019 Oct 30. pii: S0198-8859(19)31009-2. doi: 10.1016/j.humimm.2019.10.003. [Epub ahead of print]

PMID:
31677945
4.

Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes.

Loforte A, Fiorentino M, Gliozzi G, Mariani C, Folesani G, Suarez SM, Russo A, Masetti M, Potena L, Pacini D.

Transplant Proc. 2019 Nov;51(9):2962-2966. doi: 10.1016/j.transproceed.2019.07.013. Epub 2019 Oct 10.

PMID:
31607616
5.

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match.

Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E, Meiser B, Potena L, Robinson A, Rossano JW, Sadavarte A, Singh TP, Zuckermann A, Stehlik J; International Society for Heart and Lung Transplantation.

J Heart Lung Transplant. 2019 Oct;38(10):1056-1066. doi: 10.1016/j.healun.2019.08.004. Epub 2019 Aug 10. No abstract available. Erratum in: J Heart Lung Transplant. 2020 Jan;39(1):91.

6.

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match.

Chambers DC, Cherikh WS, Harhay MO, Hayes D Jr, Hsich E, Khush KK, Meiser B, Potena L, Rossano JW, Toll AE, Singh TP, Sadavarte A, Zuckermann A, Stehlik J; International Society for Heart and Lung Transplantation.

J Heart Lung Transplant. 2019 Oct;38(10):1042-1055. doi: 10.1016/j.healun.2019.08.001. Epub 2019 Aug 8. No abstract available.

7.

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match.

Rossano JW, Singh TP, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E, Khush KK, Meiser B, Potena L, Toll AE, Sadavarte A, Zuckermann A, Stehlik J; International Society for Heart and Lung Transplantation.

J Heart Lung Transplant. 2019 Oct;38(10):1028-1041. doi: 10.1016/j.healun.2019.08.002. Epub 2019 Aug 10. No abstract available.

8.

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric lung and heart-lung transplantation report-2019; Focus theme: Donor and recipient size match.

Hayes D Jr, Cherikh WS, Chambers DC, Harhay MO, Khush KK, Lehman RR, Meiser B, Rossano JW, Hsich E, Potena L, Sadavarte A, Singh TP, Zuckermann A, Stehlik J; International Society for Heart and Lung Transplantation.

J Heart Lung Transplant. 2019 Oct;38(10):1015-1027. doi: 10.1016/j.healun.2019.08.003. Epub 2019 Aug 8. No abstract available.

9.

Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction.

Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun Ö, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foà A, Leone O, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Murohara T, Arita Y, Sionis A, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Greenberg B, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG.

J Am Coll Cardiol. 2019 Jul 23;74(3):299-311. doi: 10.1016/j.jacc.2019.04.063.

PMID:
31319912
10.

Does the antibody mediated rejection grading scale have prognostic prediction? Yes, but the picture is still blurry.

Potena L, Moriconi V, Sabatino M, Agostini V, Leone O.

Curr Opin Organ Transplant. 2019 Jun;24(3):265-270. doi: 10.1097/MOT.0000000000000652.

PMID:
31090634
11.

Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review.

Paoletti E, Citterio F, Corsini A, Potena L, Rigotti P, Sandrini S, Bussalino E, Stallone G; ENTROPIA Project.

J Nephrol. 2019 Apr 27. doi: 10.1007/s40620-019-00609-y. [Epub ahead of print] Review.

PMID:
31028549
12.

Does the antibody mediated rejection grading scale have prognostic prediction? Yes, but the picture is still blurry.

Potena L, Moriconi V, Sabatino M, Agostini V, Leone O.

Curr Opin Organ Transplant. 2019 Apr 16. doi: 10.1097/MOT.0000000000000652. [Epub ahead of print]

PMID:
31008740
13.

Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy.

Foà A, Agostini V, Rapezzi C, Olivotto I, Corti B, Potena L, Biagini E, Martin Suarez S, Rotellini M, Cecchi F, Stefano P, Coppini R, Ferrantini C, Bacchi Reggiani ML, Leone O.

Int J Cardiol. 2019 Sep 15;291:77-82. doi: 10.1016/j.ijcard.2019.03.060. Epub 2019 Mar 28.

14.

An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms.

Parkes MD, Aliabadi AZ, Cadeiras M, Crespo-Leiro MG, Deng M, Depasquale EC, Goekler J, Kim DH, Kobashigawa J, Loupy A, Macdonald P, Potena L, Zuckermann A, Halloran PF.

J Heart Lung Transplant. 2019 Jun;38(6):636-646. doi: 10.1016/j.healun.2019.01.1318. Epub 2019 Feb 6.

PMID:
30795962
15.

Liver and kidney function in refractory heart failure: The narrow gate to achieve post-transplant survival.

Masetti M, Potena L.

Clin Res Hepatol Gastroenterol. 2019 Apr;43(2):115-116. doi: 10.1016/j.clinre.2018.04.004. Epub 2019 Feb 5.

PMID:
30737023
16.

Exploring the cardiac response to injury in heart transplant biopsies.

Halloran PF, Reeve J, Aliabadi AZ, Cadeiras M, Crespo-Leiro MG, Deng M, Depasquale EC, Goekler J, Jouven X, Kim DH, Kobashigawa J, Loupy A, Macdonald P, Potena L, Zuckermann A, Parkes MD.

JCI Insight. 2018 Oct 18;3(20). pii: 123674. doi: 10.1172/jci.insight.123674.

17.

Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.

Legendre C, Viebahn R, Fehrman-Ekholm I, Masnou N, Berenguer M, Potena L, Wennberg L, O'Grady J, Epailly E, Diekmann F, Binet I, Schwenger V, Kuypers D, Guthoff M.

Transplantation. 2018 Sep;102(9S Suppl 1):S1-S14. doi: 10.1097/TP.0000000000002316. No abstract available.

PMID:
30113932
18.

P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.

D'Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, Bassi R, Tezza S, Dellepiane S, El Essawy B, Iascone M, Iacovoni A, Borgese L, Liu K, Visner G, Dhe-Paganon S, Corradi D, Abdi R, Starling RC, Folli F, Zuccotti GV, Sayegh MH, Heeger PS, Chandraker A, Grigioni F, Fiorina P.

J Clin Invest. 2018 Aug 1;128(8):3490-3503. doi: 10.1172/JCI94524. Epub 2018 Jul 16.

19.

Complications of Cardiac Transplantation.

Potena L, Zuckermann A, Barberini F, Aliabadi-Zuckermann A.

Curr Cardiol Rep. 2018 Jul 10;20(9):73. doi: 10.1007/s11886-018-1018-3. Review.

PMID:
29992503
20.

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.

Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-Caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-Migaj E, McDonagh T, Seferovic P, Ruschitzka F.

Eur J Heart Fail. 2018 Nov;20(11):1505-1535. doi: 10.1002/ejhf.1236. Epub 2018 Jul 17. Review.

21.

Pregnancy and Heart Transplantation: Giving Birth After a New Life.

Potena L, Moriconi V, Presta E.

Transplantation. 2018 Sep;102(9):1411-1412. doi: 10.1097/TP.0000000000002282. No abstract available.

PMID:
29762459
22.

Coronary artery disease in heart transplantation: new concepts for an old disease.

Langstraat M, Musters KJS, Manintveld O, Masetti M, Potena L.

Transpl Int. 2018 Aug;31(8):787-827. doi: 10.1111/tri.13141. Epub 2018 Mar 26. Review.

23.

The management of antibodies in heart transplantation: An ISHLT consensus document.

Kobashigawa J, Colvin M, Potena L, Dragun D, Crespo-Leiro MG, Delgado JF, Olymbios M, Parameshwar J, Patel J, Reed E, Reinsmoen N, Rodriguez ER, Ross H, Starling RC, Tyan D, Urschel S, Zuckermann A.

J Heart Lung Transplant. 2018 May;37(5):537-547. doi: 10.1016/j.healun.2018.01.1291. Epub 2018 Jan 31.

PMID:
29452978
24.

Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.

Chiereghin A, Potena L, Borgese L, Gibertoni D, Squarzoni D, Turello G, Petrisli E, Piccirilli G, Gabrielli L, Grigioni F, Lazzarotto T.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01040-17. doi: 10.1128/JCM.01040-17. Print 2018 Apr.

25.

Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART.

Potena L, Pellegrini C, Grigioni F, Amarelli C, Livi U, Maccherini M, Masciocco G, Faggian G, Lilla Della Monica P, Gerosa G, Marraudino N, Corda M, Boffini M; EVERHEART Investigators.

Transplantation. 2018 Mar;102(3):493-501. doi: 10.1097/TP.0000000000001945.

26.

Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System.

Halloran PF, Potena L, Van Huyen JD, Bruneval P, Leone O, Kim DH, Jouven X, Reeve J, Loupy A.

J Heart Lung Transplant. 2017 Nov;36(11):1192-1200. doi: 10.1016/j.healun.2017.05.029. Epub 2017 May 29.

PMID:
28662985
27.

The Conundrum of Equitable Organ Allocation in Heart Transplantation: The Moving Target of Candidate Risk Score.

Potena L, Khush KK.

Transplantation. 2017 Sep;101(9):1969-1970. doi: 10.1097/TP.0000000000001841. No abstract available.

PMID:
28590947
28.

Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation.

Chiereghin A, Barozzi P, Petrisli E, Piccirilli G, Gabrielli L, Riva G, Potenza L, Cappelli G, De Ruvo N, Libri I, Maggiore U, Morelli MC, Potena L, Todeschini P, Gibertoni D, Labanti M, Sangiorgi G, La Manna G, Pinna AD, Luppi M, Lazzarotto T.

Transplantation. 2017 Aug;101(8):1935-1944. doi: 10.1097/TP.0000000000001740.

PMID:
28333859
29.

Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes.

Sabatino M, Vitale G, Manfredini V, Masetti M, Borgese L, Maria Raffa G, Loforte A, Martin Suarez S, Falletta C, Marinelli G, Clemenza F, Grigioni F, Potena L.

J Heart Lung Transplant. 2017 Nov;36(11):1217-1225. doi: 10.1016/j.healun.2017.02.014. Epub 2017 Feb 17.

PMID:
28302502
30.

Antibody-mediated rejection in heart transplantation: new developments and old uncertainties.

Manfredini V, Leone O, Agostini V, Potena L.

Curr Opin Organ Transplant. 2017 Jun;22(3):207-214. doi: 10.1097/MOT.0000000000000407. Review.

PMID:
28301387
31.

Heart allograft preservation: an arduous journey from the donor to the recipient.

Erasmus M, Neyrink A, Sabatino M, Potena L.

Curr Opin Cardiol. 2017 Feb 24. doi: 10.1097/HCO.0000000000000395. [Epub ahead of print]

PMID:
28240643
32.

The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions.

Bruneval P, Angelini A, Miller D, Potena L, Loupy A, Zeevi A, Reed EF, Dragun D, Reinsmoen N, Smith RN, West L, Tebutt S, Thum T, Haas M, Mengel M, Revelo P, Fedrigo M, Duong Van Huyen JP, Berry GJ.

Am J Transplant. 2017 Jan;17(1):42-53. doi: 10.1111/ajt.14112. Epub 2016 Dec 12.

33.

Cholesterol efflux capacity: A weak player in the complex plot of cardiac allograft vasculopathy.

Masetti M, Potena L.

J Heart Lung Transplant. 2016 Nov;35(11):1286-1288. doi: 10.1016/j.healun.2016.08.020. Epub 2016 Aug 30. No abstract available.

PMID:
27692538
34.

Unraveling the Process of the Dying Heart: Do Not Leave Science Alone for the Heart to Live Again.

Potena L.

Transplantation. 2016 Dec;100(12):2521-2523. No abstract available.

PMID:
27495748
35.

Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.

Potena L, Solidoro P, Patrucco F, Borgese L.

Expert Opin Pharmacother. 2016 Aug;17(12):1611-22. doi: 10.1080/14656566.2016.1199684. Epub 2016 Jun 30. Review.

PMID:
27340928
36.

Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.

Rea F, Potena L, Yonan N, Wagner F, Calabrese F.

Transplantation. 2016 Mar;100 Suppl 3:S19-26. doi: 10.1097/TP.0000000000001096. Review.

37.

Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.

Grossi P, Mohacsi P, Szabolcs Z, Potena L.

Transplantation. 2016 Mar;100 Suppl 3:S1-4. doi: 10.1097/TP.0000000000001094.

38.

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.

Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HJ, Taylor DO, Verschuuren EA, Zuckermann A; International Society for Heart Lung Transplantation (ISHLT) Infectious Diseases Council; International Society for Heart Lung Transplantation (ISHLT) Pediatric Transplantation Council; International Society for Heart Lung Transplantation (ISHLT) Heart Failure and Transplantation Council.

J Heart Lung Transplant. 2016 Jan;35(1):1-23. doi: 10.1016/j.healun.2015.10.023. No abstract available.

PMID:
26776864
39.

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.

OʼLeary JG, Samaniego M, Barrio MC, Potena L, Zeevi A, Djamali A, Cozzi E.

Transplantation. 2016 Jan;100(1):39-53. doi: 10.1097/TP.0000000000000869. Review.

40.

Antithymocyte Globulins in Heart Transplantation: Rational Dosing for a Magic Potion.

Potena L, Cozzi E.

Transplantation. 2016 Mar;100(3):483-4. doi: 10.1097/TP.0000000000000951. No abstract available.

PMID:
26569065
41.

Novel therapeutic and diagnostic management of heart transplant patients.

D'Addio F, Margonato D, Pensato U, Borgese L, Potena L, Fiorina P.

Heart Lung Vessel. 2015;7(3):198-207.

42.

The International Society for Heart and Lung Transplantation Registries in the Era of Big Data With Global Reach.

Stehlik J, Mehra MR, Sweet SC, Kirklin JK, Cypel M, Kirk R, Dipchand AI, Van Raemdonck D, Edwards LB, Mario Bertolotti A, Mejia JC, Torres Navas A, Potena L, Akar R, West LJ, Zuckermann A, Khaliel F, Davis DR, Reichenspurner H.

J Heart Lung Transplant. 2015 Oct;34(10):1225-32. doi: 10.1016/j.healun.2015.08.001. Epub 2015 Aug 28. No abstract available.

PMID:
26454736
43.

Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation.

Potena L, Masetti M, Sabatino M, Bacchi-Reggiani ML, Pece V, Prestinenzi P, Dall'Ara G, Taglieri N, Saia F, Fallani F, Magnani G, Rapezzi C, Grigioni F.

J Heart Lung Transplant. 2015 Sep;34(9):1146-53. doi: 10.1016/j.healun.2015.01.990. Epub 2015 Feb 7.

PMID:
25843518
44.

Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.

Fedrigo M, Leone O, Burke MM, Rice A, Toquet C, Vernerey D, Frigo AC, Guillemain R, Pattier S, Smith J, Lota A, Potena L, Bontadini A, Ceccarelli C, Poli F, Feltrin G, Gerosa G, Manzan E, Thiene G, Bruneval P, Angelini A, Duong Van Huyen JP.

Am J Transplant. 2015 Feb;15(2):526-34. doi: 10.1111/ajt.12976.

45.

[Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].

Loforte A, Pilato E, Martin Suarez S, Folesani G, Jafrancesco G, Castrovinci S, Cefarelli M, Potena L, Magnani G, Grigioni F, Caramelli F, Frascaroli G, Di Bartolomeo R, Marinelli G.

G Ital Cardiol (Rome). 2014 Oct;15(10):577-85. doi: 10.1714/1672.18312. Italian.

PMID:
25424022
46.

mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern?

Holdaas H, Potena L, Saliba F.

Transplant Rev (Orlando). 2015 Apr;29(2):93-102. doi: 10.1016/j.trre.2014.08.003. Epub 2014 Aug 27. Review.

PMID:
25227328
47.

Medium-term outcome of recipients of marginal donor hearts selected with new stress-echocardiographic techniques over standard criteria.

Bombardini T, Arpesella G, Maccherini M, Procaccio F, Potena L, Bernazzali S, Leone O, Picano E.

Cardiovasc Ultrasound. 2014 Jun 16;12:20. doi: 10.1186/1476-7120-12-20.

48.

Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy.

Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M, Potena L, Leone O, Bartolomei I, Pastorelli F, Salvi F, Rapezzi C.

JACC Cardiovasc Imaging. 2014 May;7(5):531-2. doi: 10.1016/j.jcmg.2014.03.004. No abstract available.

49.

Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle.

Potena L, Quarta CC, Grigioni F, Rapezzi C.

J Heart Lung Transplant. 2014 Feb;33(2):136-8. doi: 10.1016/j.healun.2013.11.007. Epub 2013 Nov 27. No abstract available.

PMID:
24480447
50.

Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis.

Cornu C, Dufays C, Gaillard S, Gueyffier F, Redonnet M, Sebbag L, Roussoulières A, Gleissner CA, Groetzner J, Lehmkuhl HB, Potena L, Gullestad L, Cantarovich M, Boissonnat P.

Br J Clin Pharmacol. 2014 Jul;78(1):24-32. doi: 10.1111/bcp.12289. Review.

Supplemental Content

Loading ...
Support Center